References

Baranova, А.А. and R.М. Khaitova, 2010. Allergology and immunology under the general editorship. Union of Pediatricians of Russia, Russia.

Devillier, P., N. Roche and C. Faisy, 2008. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine. Clin. Pharmacokinet., 47: 217-230.
CrossRef  |  Direct Link  |  

Dicpinigaitis, P.V. and Y.E. Gayle, 2003. Effect of the second generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function. Br. J. Clin. Pharmacol., 56: 501-504.
CrossRef  |  PubMed  |  Direct Link  |  

Gladyshev, V.V., 2013. The analysis of the impact of carrier-bases on the intensity of the captopril release from nasal soft dosage forms. J. Kuban Sci. Med. Vestnik, 5: 69-73.

Handa, S., S. Dogra and B. Kumar, 2004. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. J. Dermatological Treat., 15: 55-57.
Direct Link  |  

Korotkiy, N.G., 2001. Modern external therapy of dermatosis. Tver J. Gubernskaya Med., 5: 85-99.

Kozachok, N.N., L.V. Kuznetsova, А.P. Grishilo and М.N. Selyuk, 2003. Clinical efficiency of altive drug administration in the urticarial fever treatment. J. Dermatol., 4: 38-40.

Leonova, М.V., 2011. Modern antihistamines: The choice in the superfluity of proposals. J. Pharmateka, 10: 26-32.

Popova, Z.N. and I.V. Sakhanda, 2015. Rheologic characteristics and medical properties of soft dosage forms. Int. Sci. Inst. Educ., 9: 78-80.

Simons, F.E.R. and K.J. Simons, 2011. Histamine and H 1-antihistamines: Celebrating a century of progress. J. Allergy Clin. Immunol., 128: 1139-1150.
CrossRef  |  PubMed  |  Direct Link  |  

Vasilchuk, Е.F., А.Т. Ostapenko and Е.М. Schekaturova, 2013. Treatment of allergodermathosis with a 3rd generation decongestant decongestant-altiva. J. Dermatology, 1: 40-41.

Weller, K., C. Ziege, P. Staubach, K. Brockow and F. Siebenhaar et al., 2011. H 1-Antihistamine up-dosing in chronic spontaneous urticaria: Patients' perspective of effectiveness and side effects a retrospective survey study. PloS. One, Vol. 6, 10.1371/journal.pone.0023931

Wilson, A.M., L.C. Orr, W.J.R. Coutie, E.J. Sims and B.J. Lipworth, 2002. A comparison of once daily fexofenadine versus the combination of monte-lukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis. Clin. Exp. Allergy, 32: 126-132.
CrossRef  |  Direct Link  |